Marinos C. Dalakas

41.8k total citations · 7 hit papers
415 papers, 28.2k citations indexed

About

Marinos C. Dalakas is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Marinos C. Dalakas has authored 415 papers receiving a total of 28.2k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Neurology, 127 papers in Epidemiology and 93 papers in Molecular Biology. Recurrent topics in Marinos C. Dalakas's work include Peripheral Neuropathies and Disorders (133 papers), Inflammatory Myopathies and Dermatomyositis (113 papers) and Autoimmune Neurological Disorders and Treatments (78 papers). Marinos C. Dalakas is often cited by papers focused on Peripheral Neuropathies and Disorders (133 papers), Inflammatory Myopathies and Dermatomyositis (113 papers) and Autoimmune Neurological Disorders and Treatments (78 papers). Marinos C. Dalakas collaborates with scholars based in United States, Greece and Germany. Marinos C. Dalakas's co-authors include Reinhard Hohlfeld, Harry Alexopoulos, Isabel Illa, William Lewis, James M. Dambrosia, Raghavan Raju, G. Pezeshkpour, Goran Rakočević, Mavis Fujii and Lev G. Goldfarb and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Marinos C. Dalakas

410 papers receiving 27.3k citations

Hit Papers

Polymyositis and dermatom... 1990 2026 2002 2014 2003 1993 1991 1991 1990 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Polymyositis and dermatomyositis
    2003 1.0k citations Marinos C. Dalakas et al. The Lancet profile →
  2. A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
    1993 747 citations Marinos C. Dalakas et al. profile →
  3. A New Approach to the Classification of Idiopathic Inflammatory Myopathy
    1991 694 citations Marinos C. Dalakas et al. profile →
  4. Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
    1991 678 citations Marinos C. Dalakas profile →
  5. Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
    1990 637 citations Marinos C. Dalakas et al. profile →
  6. Mitochondrial toxicity of antiviral drugs
    1995 605 citations Marinos C. Dalakas et al. profile →
  7. Inflammatory Muscle Diseases
    2015 507 citations Marinos C. Dalakas profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marinos C. Dalakas United States 88 10.6k 8.9k 7.0k 5.5k 4.6k 415 28.2k
Andrew G. Engel United States 86 7.1k 0.7× 3.7k 0.4× 12.2k 1.7× 3.3k 0.6× 2.3k 0.5× 359 22.7k
Moses Rodriguez United States 79 6.1k 0.6× 2.1k 0.2× 5.4k 0.8× 2.3k 0.4× 3.0k 0.7× 489 27.0k
Angela Vincent United Kingdom 105 31.0k 2.9× 2.8k 0.3× 7.6k 1.1× 5.0k 0.9× 3.2k 0.7× 677 39.5k
Francesc Graus Spain 99 28.3k 2.7× 4.9k 0.6× 5.7k 0.8× 6.6k 1.2× 2.0k 0.4× 437 35.2k
Richard M. Ransohoff United States 116 5.9k 0.6× 2.7k 0.3× 12.2k 1.7× 5.9k 1.1× 3.0k 0.7× 352 54.3k
Reinhard Hohlfeld Germany 82 6.0k 0.6× 2.9k 0.3× 5.6k 0.8× 1.8k 0.3× 3.3k 0.7× 301 23.0k
Vanda A. Lennon United States 97 26.2k 2.5× 1.9k 0.2× 7.9k 1.1× 4.3k 0.8× 5.9k 1.3× 395 41.5k
Tomas Olsson Sweden 92 5.5k 0.5× 2.6k 0.3× 5.8k 0.8× 2.2k 0.4× 4.0k 0.9× 679 31.2k
Wolfgang Brück Germany 89 6.8k 0.6× 2.1k 0.2× 7.7k 1.1× 3.9k 0.7× 3.2k 0.7× 391 32.1k
Nobuo Hashimoto Japan 74 8.1k 0.8× 1.8k 0.2× 5.7k 0.8× 3.0k 0.5× 3.3k 0.7× 590 22.2k

Countries citing papers authored by Marinos C. Dalakas

Since Specialization
Citations

This map shows the geographic impact of Marinos C. Dalakas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marinos C. Dalakas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marinos C. Dalakas more than expected).

Fields of papers citing papers by Marinos C. Dalakas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marinos C. Dalakas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marinos C. Dalakas. The network helps show where Marinos C. Dalakas may publish in the future.

Co-authorship network of co-authors of Marinos C. Dalakas

This figure shows the co-authorship network connecting the top 25 collaborators of Marinos C. Dalakas. A scholar is included among the top collaborators of Marinos C. Dalakas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marinos C. Dalakas. Marinos C. Dalakas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexopoulos, Harry, Konstantinos Kyriakidis, Sofia Akrivou, et al.. (2025). Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and KLK10 -Gene Variants. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200373–e200373. 1 indexed citations
2.
Dalakas, Marinos C.. (2025). Promising Effects of CAR T-Cell Therapy in Refractory Stiff Person Syndrome and a Hopeful Future for All Neuroautoimmunities. Neurology Neuroimmunology & Neuroinflammation. 13(1). e200511–e200511.
3.
Artemiadis, Artemios, et al.. (2024). The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile. Neurological Sciences. 45(11). 5405–5411. 6 indexed citations
4.
Dalakas, Marinos C.. (2023). Therapies in Stiff-Person Syndrome. Neurology Neuroimmunology & Neuroinflammation. 10(3). 22 indexed citations
5.
Stathopoulos, Panos & Marinos C. Dalakas. (2022). The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders. Expert Review of Clinical Immunology. 18(9). 933–945. 12 indexed citations
6.
Toulas, Panagiotis, Georgios Koutsis, Maria‐Eleftheria Evangelopoulos, et al.. (2022). Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(8). 933–943. 9 indexed citations
7.
Evangelopoulos, Maria‐Eleftheria, Georgios Velonakis, George P. Chrousos, et al.. (2021). Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data. Neurological Sciences. 43(4). 2641–2649. 8 indexed citations
8.
Anagnostouli, Maria, Georgios Velonakis, & Marinos C. Dalakas. (2021). Aggressive Herpes Zoster in Young Patients With Multiple Sclerosis Under Dimethyl Fumarate. Neurology Neuroimmunology & Neuroinflammation. 8(4). 6 indexed citations
9.
Dalakas, Marinos C., Harry Alexopoulos, & Peter J. Spaeth. (2020). Complement in neurological disorders and emerging complement-targeted therapeutics. Nature Reviews Neurology. 16(11). 601–617. 235 indexed citations
10.
Dalakas, Marinos C., et al.. (2019). A Report on LGI1 Encephalitis in association with Squamous Cell Carcinoma of the Lung (P2.2-028). Neurology. 92(15_supplement).
11.
Markakis, Ioannis, Harry Alexopoulos, Cornelia Poulopoulou, et al.. (2014). Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase. Journal of the Neurological Sciences. 343(1-2). 192–194. 19 indexed citations
12.
13.
Toro, Camilo, Montse Olivé, Marinos C. Dalakas, et al.. (2013). Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurology. 13(1). 29–29. 28 indexed citations
14.
Deng, C. Q., Kim Hanna, Vera Bril, et al.. (2011). Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design. Journal of Neurology. 259(2). 348–352. 14 indexed citations
15.
16.
Dalakas, Marinos C.. (2004). Chapter 29 Molecular pathogenesis of inflammatory myopathies and future therapeutic strategies. Supplements to Clinical neurophysiology. 57. 288–303. 4 indexed citations
17.
Dalakas, Marinos C., Harry Bartfeld, & Leonard T. Kurland. (1995). The Post-polio syndrome : advances in the pathogenesis and treatment. New York Academy of Sciences eBooks. 19 indexed citations
18.
Arnaudo, E., et al.. (1991). Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. The Lancet. 337(8740). 508–510. 399 indexed citations
19.
Gahl, William A., Isa Bernardini, Marinos C. Dalakas, et al.. (1988). Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.. Journal of Clinical Investigation. 81(2). 549–560. 33 indexed citations
20.
Dalakas, Marinos C., Jun Hatazawa, Rodney A. Brooks, & Giovanni Di Chiro. (1987). Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Annals of Neurology. 22(5). 580–586. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew G. Engel Breakdown of academic impact, for papers by Moses Rodriguez Breakdown of academic impact, for papers by Angela Vincent Breakdown of academic impact, for papers by Francesc Graus Breakdown of academic impact, for papers by Richard M. Ransohoff Breakdown of academic impact, for papers by Reinhard Hohlfeld Breakdown of academic impact, for papers by Vanda A. Lennon Breakdown of academic impact, for papers by Tomas Olsson Breakdown of academic impact, for papers by Wolfgang Brück Breakdown of academic impact, for papers by Nobuo Hashimoto
Rankless by CCL
2026